car t-cell update: what’s new in dlbcl and mm?
Published 6 years ago • 93 plays • Length 2:55Download video MP4
Download video MP3
Similar videos
-
3:39
updates on car t-cells in lymphoma
-
4:22
carcik trial updates: using sb-engineered car-t cells in patients with b-all
-
8:50
an update of car t-cell therapies in lymphoma
-
3:05
can car-t cells replace asct in dlbcl?
-
2:06
can car-t cells replace asct in dlbcl?
-
7:36
is car t-cell therapy the future of cancer treatment?
-
11:18
car-t cells: engineered cancer killers
-
9:11
chimeric antigen receptor car technique - creative biolabs (original version)
-
3:47
can car-t cells replace asct in dlbcl?
-
2:30
car-t as a new standard of care in lymphoma
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
3:05
car-t therapy in r/r dlbcl
-
1:27
car t-cells in all: an overview
-
1:22
update on car t-cell therapy at the city of hope
-
2:38
car t-cells improve response and cr rates in r/r dlbcl
-
11:47
what's the latest on car-t in all?
-
1:58
car t-cell therapy and all: the current landscape
-
2:21
cd58 status impacts car t-cell activity in lbcl patients
-
1:56
the state of car t-cell products today
-
1:42
car-t updates in aml and all
-
2:11
improving treatment outcomes of car t-cell therapy
-
2:22
car t-cell immunotherapy: current status and perspectives